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A tropomyosin-binding protein (abp. M, 17000) was detected in equine platelet preparations by a gel 
overlay technique. Its isolation, amino acid and partial sequence analyses have shown it to be histone H2B. 
As with a similar protein from pig platelet preparations fder Terrossian et al. (1983) FEBS Lett. 152, 
202-2061, it inhibits Mg’+-dependent actomyosin Sl ATPase. This inhibition is partially reversed in the 
presence of cahnodulin and Ca2+ but is not potentiated, unlike troponin-I, by tropomyosin. This protein, 
along with the other histones, is almost certainly derived from a low level of contaminating nucleated cells 
in most platelet preparations. 
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1 s INTRODUCTION 
The study of contractile mechanisms in non- 
muscle cells has led to the identifi~tion of a large 
number of actin-binding proteins [1] which fulfill 
a wide variety of functions including cross-linking, 
length regulation and capping of the actin 
filaments. The actin-binding protein tropomyosin 
(TM) has been identified in the platelet [2], and 
~though many of its properties have been 
documented [3-51, a specific role in vivo for the 
protein in the non-muscle system has not, as yet, 
been described. Although skeletal TMs give stabili- 
ty to actin filaments [6-81, this may not be the only 
role of the platelet protein which binds only weakly 
to F-actin under conditions considered physio- 
logical [9]. 
A recent receptor [ 101 describes the purification 
of a basic Tn-I like protein from pig platelets, 
which binds to c~modulin and inhibits the actin- 
activated Mg2+-dependent ATPase activity of 
skeletal muscle myosin. Here, we have isolated a 
basic TM-binding protein of similar molecular 
mass which also inhibits the actin-activated 
Mg+-dependent ATPase of myosin Sl , but not in 
a specific manner. We identify this protein, which 
has an app. Mr of 17000 on SDS gels, as the core 
histone, H2B, which has previously been shown to 
bind to c~mod~in in a Ca2+-dependent manner 
IllI. 
2. METHODS 
2.1. Protein preparation 
~almodulin was prepared from bovine brain 
(121 and platelet TM as in [3]. Histones were 
isolated from bovine thymus [13]. 
2.2. Analytical methods 
Abbreviations: SDS, sodium dodecyl sulfate; EGTA, Amino terminal sequence data were obtained by 
ethylene glycolbis@?-amino-ethyl ether)-N,N,N’,N’-tet- automatic Edman degradation as in [14]. ATPase 
raacetic acid; TM, tropomyosin; Tn-T, troponin-T; assays were performed by the pH stat method 
Tn-I, troponin-I; Tn-C, troponin-C; kDa, kilo d&on; described in 141. SDS-polyacrylamide gel elec- 
DTT, dit~othreitol trophoresis was performed as in [IS]. DNA was 
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determined as in [16]. The method in [ 171 was 
modified for the identification of TM-binding pro- 
teins by gel overlay, using a ‘binding buffer’ con- 
sisting of 10 mM MgC12, 100 mM KCI, 1 mM 
EGTA, 2 mM DTT, 2 mM ATP and 10 mM 
Tris-HCl, pH 7.5. 
2.3. Purification of 17 kDa TM-binding protein 
A 10-g sample of lyophilized equine platelets, 
prepared as in [3], was suspended in 300 ml of 1 M 
KCI, 1 mM DTT, 10 mM Tris-HCl, 1 mM EGTA 
(pH 7.4) containing 0.2 pug/ml pepstatin, 
0.2 ,ug/ml leupeptin and 0.1 mM phenylmethane 
sulfonyl fluoride. The suspension was homogeniz- 
ed briefly and then further extracted by stirring for 
30 min. The combined extracts were centrifuged at 
50000 x g for 60 min and the supernatant dialyzed 
against 3 changes of 0.1 M NaCl, 1 mM DTT, 
1 mM EGTA, 10 mM Tris (pH 7.4) overnight. 
This fraction was adjusted to pH 4.5 with 5 M HCl 
and centrifuged at 10000 x g for 10 min. The 
supernatant was dialyzed against 3 changes of 
water overnight and concentrated by lyophiliza- 
tion. All procedures were performed at 4°C. 
The protein powder was suspended in 20 ml of 
5% formic acid, and centrifuged at 5000 x g for 
10 min. The supernatant, which had an A&r? of 
6-7, was applied to a 2.5 x 200 cm GSO Sephadex 
column with a flow rate of 20 ml/h in 5% formic 
acid. Fractions were monitored for protein at 
280 nm. The 17 kDa protein was eluted in the first 
peak following the void volume peak. This frac- 
tion (50-60 mg protein) was lyophilized and then 
dissolved in 20 ml of 8 M urea, 50 mM cacodylate 
buffer (pH 6.5) and applied to a 1.2 x 25 cm 
CM52 cellulose column. Proteins were eluted with 
a 0.0-0.3 M KC1 linear gradient in the sample buf- 
fer. The column was run at 10 ml/h. The 17 kDa 
protein was eluted at 0.16-o. 18 M KCl. This peak 
represented lo-20 mg of protein purified from 
10 g platelets. 
3. RESULTS AND DISCUSSION 
3.1. Identification and characterization of a 
I7 kDa TM-binding protein 
Using 1251-labelled platelet TM as a probe in the 
gel overlay technique, a band with an app. M, of 
17000 was identified on autoradiograms of 13% 
SDS-polyacrylamide gels of whole platelets. In 
130 
control experiments it was demonstrated that 
[1251]TM bound to standard actin, Tn-I and Tn-T. 
The 17 kDa protein was isolated as described 
above. The protein, which is basic, runs as a close 
doublet on SDS-polyacrylamide gels in the 
16-17 kDa region, and was judged to be greater 
than 95% pure. Its amino acid composition (table 
1) is very similar to the bovine core histone H2B 
and the first 20 residues of its N-terminal sequence 
were found to be identical to this protein. 
The binding of the protein to TM was confirmed 
by an affinity chromatographic procedure using 
platelet TM immobilized on Sepharose 4B. It was 
eluted with a salt gradient from this column at the 
same position as calf thymus histone H2B. An 
equimolar mixture of the core histones, H2A, 
H2B, H3 and H4 did not bind to this column. The 
17 kDa protein was also shown to bind to F-actin 
by pelleting experiments [5]. The 17 kDa protein 
comigrated with H2B on SDS-polyacrylamide gels 
Table 1 
Amino acid analysis of equine platelet 17 kDa protein 
Amino acid composition 
(mol/mol of peptide) 
Platelet Bovine Bovine 
uterus thymus 
17 kDa protein* histone H2B histone H2Bb 
1111 
ASP 6.1 7.8 
THR 8.3 7.1 
SER 10.1 10.6 
GLU 11.4 11.6 
PRO 5.8 6.6 
GLY 8.5 10.0 
ALA 13.9 12.6 
VAL 8.2 8.2 
MET 1.6 1.7 
ILE 6.3 5.9 
LEU 8.0 8.9 
TYR 4.7 4.1 
PHE 2.6 2.6 
HIS 2.8 3.4 
LYS 15.9 15.9 
ARG 11.4 8.9 
TRP 0.0 0.0 
CYS 0.0 n.d. 
a Calculated from an I%& of 13700 
b From the sequence of [21] and [22] 
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and in view of these findings we conclude that the 
17 kDa TM-binding protein is histone H2B. This 
protein, of M, 13 700, runs with an anomalous high 
molecular mass on SDS gels. 
3.2. Comparison of I7 kDa protein with Tn-I 
A comparison of the effects of Tn-I, 17 kDa 
protein and salmine on the actin-activated Mg2+ 
ATPase of skeletal muscle myosin Sl in the 
absence and presence of platelet TM is shown in 
fig.1. Although the inhibitory activity of Tn-I is 
markedly potentiated by TM, that of the 17 kDa 
protein shows no such effect, and higher molar 
ratios of 17 kDa protein to actin are required to 
obtain the same level of inhibition in the presence 
of TM. Salmine, a 6 kDa basic protein, also in- 
hibits the ATPase in the presence or absence of 
TM. This suggests that the inhibitory effect of the 
17 kDa protein is of a non-specific nature at- 
tributable to its small size and basic properties. We 
have also observed that the inhibition produced by 
the 17 kDa protein can be reversed by about 50% 
with the inclusion of calmodulin and Ca2+ in the 
assay. This observation is consistent with a 
previous demonstration that the interactions of 
both myelin basic protein and histone H2B with 
calmodulin are sensitive to the presence or absence 
of Ca2+ [ll]. 
80 
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In the indirect non-competitive ELISA assay, 
the 17 kDa protein showed no specific interaction 
with a polyclonal antiserum raised to SDS- 
denatured rabbit skeletal Tn-I. Lack of apparent 
sequence homology was also demonstrated by 
tryptic peptide mapping. We therefore suggest hat 
the inhibition of the ATPase is a non-specific ef- 
fect due to the binding of the basic 17 kDa protein 
to F-actin. 
3.3. Identification of histones in platelet 
preparations 
The above observations suggest hat the effects 
of the 17 kDa protein, identified as histone H2B, 
are non-specific, and that the presence of this 
histone in platelet preparations is attributable to 
contamination with low levels of nucleated white 
blood cells. All 4 core histones were shown to be 
present in our platelet preparations by their coelec- 
trophoresis with the components of a core bovine 
histone preparation on SDS-polyacrylamide gels 
and ‘spiking’ of the platelet preparation with in- 
dividual core histones. The ratios of the proteins to 
each other were the same in the platelet as in the 
core histone preparation (table 2). The individual 
histones in the latter are known to be present in a 
1: 1: 1: 1 molar ratio [18,19]. Histone Hl, which is 
less well conserved between species [20], is present 
h ’ ’ 
0 0.3 0.6 
c 
MOLAR RATIO OF INHIBITOR TO ACTIN 
Fig. 1. Inhibition of ATPase of Sl by: (A) Tn-I; (B) 17 kDa protein; (C) salmine in the presence 
(M) and absence (H) TM in a ratio to actin of 0.3 : 1. The effect of calmodulin with Ca2+ on the 
inhibition in the presence of TM is shown (ti). 
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Table 2 
Relative peak size of Coomassie-stained core histone 
protein bands on SDS-polyacrylamide gels determined 
by densitometric scanning 
% Peak size of Coomas- 
sie-stained bands* 
H2A H2B H3 H4 
Platelet preparation 21 26 30 24 
Platelet preparation spiked 
with histone complex 20 28 31 23 
Histone complex 18 25 31 26 
* Average of scans of 7 gels 
Each protein was present in the histone mixture in a 
1: 1: 1: 1 molar ratio. The results are expressed as a per- 
centage of the total peak size of the 4 histone bands 
as a novel band in the platelet preparation. Cell 
counting and DNA analyses showed that white 
blood cells were present at a level of 0.14% of the 
platelet count. Calculation of the protein content 
contributed by this level of cell contamination 
strongly suggests that the histones observed in our 
preparation were derived from this source. 
3.4. Conclusions 
A 17 kDa basic protein in equine platelet 
preparations which binds to TM and F-actin has 
been identified as histone H2B. Although it mimics 
Tn-I in its inhibition of the Mg’+-dependent ac- 
tomyosin Sl ATPase activity and in the partial 
reversal of this inhibition by calmodulin and Ca’+, 
its inhibitory action, unlike Tn-I, is not potentiated 
by platelet TM. We suggest hat a similar protein 
recently reported in pig platelet preparations [lo] is 
also histone H2B and that its presence along with 
the other core histones in a 1: 1: 1: 1 molar ratio is 
due to a low level of contamination with nucleated 
cells. Although this histone could conceivably play 
a role in the control of thin filament assembly in 
nuclei, we ascribe no function to it in the contrac- 
tile phenomena of platelet activation. 
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